Completed
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
NCT00004419
- Conditions
- Disease Attributes, Endocrine System Diseases, Glucose Metabolism Disorders, +8 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States